U-251 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF4827
Target Cell Organism: Human
Target Cell Name: U-251
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide U-251-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
U-251
Target Cell Organism
Human
Target Cell Background
The U-251 cell line was established at the Wallenberg laboratory, Uppsala, Sweden, almost more than 40 years ago along with several other cell lines derived from human gliomas, and was derived from a male patient with malignant astrocytoma.
Related Diseases
Glioblastoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
U-251-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry